Egel J, Pfanstiel J, Puschett J B
Life Sci. 1985 Nov 4;37(18):1675-81. doi: 10.1016/0024-3205(85)90294-2.
Previous studies have indicated that the thiazide diuretics exert effects on proximal electrolyte transport. To determine whether the locus of these effects is at the brush border membrane (BBM) and if renal metabolism is affected, adult female Sprague-Dawley rats were acutely treated with either 1 mg/kg metolazone, 20 mg/kg chlorothiazide followed by a 20 mg/kg/hr maintenance infusion, 10 mg/kg acetazolamide followed by a 10 mg/kg/hr maintenance infusion, or the vehicles only. Administration of these agents resulted in an approximately tenfold increase in sodium excretion. Neither urinary phosphate nor inulin excretion changed significantly in any group. Sodium dependent BBM vesicle phosphate transport was examined at 0.15, 0.5, and 1 and 120 minute incubation periods in the diuretic treated groups and their respective control groups. Decreased uptake was seen in all pre-equilibrium time points in rats treated with metolazone: 0.15 minutes: 221 +/- 24 pmoles/mg protein (pmol/mg prot) in control rats versus (vs) 185 +/- 23 pmoles/mg prot in metolazone-treated animals (P less than .05) ; 0.5 minutes: 463 +/- 54 vs 369 +/- 49 pmol/mg prot (P less than .005); 1 minute: 549 +/- 74 vs 460 +/- 61 pmol/mg prot (P less than .05); no significant difference in phosphate transport was noted at the two hour equilibrium time point. No significant differences in sodium dependent phosphate transport existed between chlorothiazide or acetazolamide treated rats and control animals. Substrate-stimulated renal gluconeogenesis did not differ between metolazone treated and control animals. We therefore conclude that metolazone inhibits phosphate transport through an effect on the BBM and does not affect renal gluconeogenesis in the rat.
以往研究表明,噻嗪类利尿剂对近端电解质转运有影响。为了确定这些作用的位点是否在刷状缘膜(BBM)以及肾脏代谢是否受到影响,对成年雌性Sprague-Dawley大鼠进行急性处理,分别给予1 mg/kg美托拉宗、20 mg/kg氯噻嗪,随后以20 mg/kg/小时的速度持续输注,10 mg/kg乙酰唑胺,随后以10 mg/kg/小时的速度持续输注,或仅给予赋形剂。给予这些药物后,钠排泄量增加了约10倍。任何一组的尿磷酸盐或菊粉排泄量均无显著变化。在利尿剂处理组及其各自的对照组中,分别在0.15、0.5、1和120分钟的孵育期检测钠依赖性BBM囊泡磷酸盐转运。在美托拉宗处理的大鼠中,所有预平衡时间点的摄取均减少:0.15分钟时,对照大鼠为221±24 pmoles/mg蛋白质(pmol/mg prot),美托拉宗处理的动物为185±23 pmoles/mg prot(P<0.05);0.5分钟时,分别为463±54和369±49 pmol/mg prot(P<0.005);1分钟时,分别为549±74和460±61 pmol/mg prot(P<0.05);在两小时平衡时间点,磷酸盐转运无显著差异。氯噻嗪或乙酰唑胺处理的大鼠与对照动物之间,钠依赖性磷酸盐转运无显著差异。美托拉宗处理的动物与对照动物之间,底物刺激的肾脏糖异生没有差异。因此,我们得出结论,美托拉宗通过对BBM的作用抑制磷酸盐转运,且不影响大鼠的肾脏糖异生。